Novo Nordisk Inc. - Comment
Posted : 01/27/2010     ID ：FDA-2009-D-0539-0004     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

MedImmune - Comment
Posted : 02/01/2010     ID ：FDA-2009-D-0539-0005     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

European Bioanalysis Forum - Interest Group Macromolecules - Comment
Posted : 02/01/2010     ID ：FDA-2009-D-0539-0006     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Covance Laboratories Inc. - Comment
Posted : 02/02/2010     ID ：FDA-2009-D-0539-0010     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Amgen, Inc. - Comment
Posted : 02/02/2010     ID ：FDA-2009-D-0539-0011     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

European Immunogenicity Platform (EIP) - Comment
Posted : 02/02/2010     ID ：FDA-2009-D-0539-0013     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Facet Biotech - Comment
Posted : 02/02/2010     ID ：FDA-2009-D-0539-0015     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Merck & Company - Comment
Posted : 02/03/2010     ID ：FDA-2009-D-0539-0017     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Biogen Idec - Comment
Posted : 02/03/2010     ID ：FDA-2009-D-0539-0018     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Biotechnology Industry Organization (BIO) - Comment
Posted : 02/03/2010     ID ：FDA-2009-D-0539-0019     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

bioLOGICA Consulting - Comment
Posted : 02/05/2010     ID ：FDA-2009-D-0539-0020     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Covance - Comment
Posted : 02/05/2010     ID ：FDA-2009-D-0539-0021     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET

Human Genome Sciences, Inc. (HGS) - Comment
Posted : 02/05/2010     ID ：FDA-2009-D-0539-0022     Agency : FDA

Comment Period Closed
Feb 02,2010 11:59 PM ET